Home / Health / New Pill Promises Significant Weight Loss
New Pill Promises Significant Weight Loss
28 Jun
Summary
- Aleniglipron, an oral drug, achieved up to 12% weight reduction.
- It increases insulin, suppresses appetite, and boosts satiety.
- Mild gastrointestinal side effects decreased over time.
A novel oral medication, aleniglipron, has demonstrated notable efficacy in weight management, according to recent research. In a study involving 230 adults with overweight or obesity across 38 U.S. medical centers, participants experienced up to a 12 percent reduction in body weight after 36 weeks of treatment.
Aleniglipron functions by stimulating insulin secretion, suppressing appetite, and enhancing satiety. Researchers noted that the drug's small-molecule nature allows it to be taken with or without food and potentially combined with other medications. Mild to moderate gastrointestinal side effects were reported but decreased as treatment progressed, with no new safety concerns identified.
This investigational drug is currently not approved by the FDA. Previous findings also indicated substantial weight loss with aleniglipron, suggesting its potential as a significant therapeutic option for obesity. Further trials are planned to optimize tolerability and efficacy.
